ArticleFrontiers in oncology2021

Bilirubin Restrains the Anticancer Effect of Vemurafenib on BRAF-Mutant Melanoma Cells Through ERK-MNK1 Signaling.

Yufan Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.